Exact Mass: 397.215

Exact Mass Matches: 397.215

Found 500 metabolites which its exact mass value is equals to given mass value 397.215, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Echimidine

7-Angelyl-9-echimidinylretronecine

C20H31NO7 (397.21)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2304 INTERNAL_ID 2304; CONFIDENCE Reference Standard (Level 1)

   

3,4-dihydroxy-2-methyl-4-farnesyl-3H-quinolin-1-ium-1-olate

3,4-Dihydroxy-2-methy-4-[(2E,6E)-farnesyl]-3,4-dihydroquinoline 1-oxide

C25H35NO3 (397.2617)


A member of the class of quinoline N-oxides that is 2-methyl-1-oxo-4-3,4-dihydroquinoline-3,4-diol carrying an additional (2E,6E)-farnesyl group at position 4.

   

Apatinib

Apatinib

C24H23N5O (397.1903)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

   

Heliosupine

7-Angelyl-9-echimidinylheliotridine

C20H31NO7 (397.21)


   

Phytosphingosine-1-P

{[(2R,3R,4R)-2-amino-3,4-dihydroxyoctadecyl]oxy}phosphonic acid

C18H40NO6P (397.2593)


Phytosphingosine-1-P is an intermediate in sphingolipid metabolism pathway. It is the enzymatic oxidation product of 4-hydroxysphinganine. Sphingolipids are essential components of the plasma membrane in all eukaryotic cells. S. cerevisiae cells make three complex sphingolipids: inositol-phosphoceramide (IPC), mannose-inositol-phosphoceramide (MIPC), and mannosyl-diinositol-phosphorylceramide (M(IP)2C) [ Dickson02 ]. In the yeast plasma membrane sphingolipids concentrate with ergosterol to form lipid rafts, specialized membrane microdomains implicated in a variety of cellular processes, including sorting of membrane proteins and lipids, as well as organizing and regulating signaling cascades [ Bagnat02 ]. Intermediates in sphingolipid biosynthesis have been shown to play important roles as signaling molecules and growth regulators. Sphingolipid long chain bases (LCBs), dihydrosphingosine (DHS) and phytosphingosine (PHS), have been implicated as secondary messengers in signaling pathways that regulate heat stress response. Other intermediates, phytoceramide and long-chain base phosphates (LCBPs), have been shown to be components of tightly-controlled ceramide/LCBP rheostat, which regulates cell growth. Since phosphoinositol-containing sphingolipids are unique to fungi, the sphingolipid biosynthesis pathway is considered a target for antifungal drugs. Phytosphingosine-1-p, also known as phs-1-phosphate, is a member of the class of compounds known as phosphosphingolipids. Phosphosphingolipids are sphingolipids with a structure based on a sphingoid base that is attached to a phosphate head group. They differ from phosphonospingolipids which have a phosphonate head group. Phytosphingosine-1-p is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Phytosphingosine-1-p can be found in a number of food items such as dandelion, common verbena, turmeric, and fennel, which makes phytosphingosine-1-p a potential biomarker for the consumption of these food products.

   

Drotaverine

(1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline

C24H31NO4 (397.2253)


Drotaverine (INN, also known as drotaverin) is an antispasmodic drug, structurally related to papaverine. Drotaverine is a selective inhibitor of phosphodiesterase 4, and has no anticholinergic effects. Drotaverine has been shown to possess dose-dependant analgesic effects in animal models. One small study has shown drotaverine to be eliminated mainly non-renally. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AD - Papaverine and derivatives C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Tetradeca-9,11-dienedioylcarnitine

3-[(13-carboxytrideca-9,11-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C21H35NO6 (397.2464)


Tetradeca-9,11-dienedioylcarnitine is an acylcarnitine. More specifically, it is an tetradeca-9,11-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Tetradeca-9,11-dienedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine Tetradeca-9,11-dienedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(6E,9E)-Tetradeca-6,9-dienedioylcarnitine

3-[(13-carboxytrideca-6,9-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C21H35NO6 (397.2464)


(6E,9E)-Tetradeca-6,9-dienedioylcarnitine is an acylcarnitine. More specifically, it is an (6E,9E)-tetradeca-6,9-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (6E,9E)-Tetradeca-6,9-dienedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (6E,9E)-Tetradeca-6,9-dienedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E,4Z)-Tetradeca-2,4-dienedioylcarnitine

3-[(13-carboxytrideca-2,4-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C21H35NO6 (397.2464)


(2E,4Z)-Tetradeca-2,4-dienedioylcarnitine is an acylcarnitine. More specifically, it is an (2E,4Z)-tetradeca-2,4-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E,4Z)-Tetradeca-2,4-dienedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (2E,4Z)-Tetradeca-2,4-dienedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

1-(3,4-Diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinoline

1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-3,4-dihydroisoquinoline

C24H31NO4 (397.2253)


   

4-Tetradecanamidobenzylphosphonic acid

[(4-tetradecanamidophenyl)methyl]phosphonic acid

C21H36NO4P (397.2382)


   

Comfrey

7-({[2,3-dihydroxy-2-(propan-2-yl)butanoyl]oxy}methyl)-1-[(2-methylbut-2-enoyl)oxy]-1,2,3,4,5,7a-hexahydropyrrolizin-4-ium-4-olate

C20H31NO7 (397.21)


   

Apatinib

N-[4-(1-cyanocyclopentyl)phenyl]-2-{[(pyridin-4-yl)methyl]amino}pyridine-3-carboxamide

C24H23N5O (397.1903)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

   

4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine

1-[4-(2H-1,2,3,4-tetrazol-5-yl)butyl]-4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene}piperidine

C25H27N5 (397.2266)


   

Methyl N-({(2s,3s)-3-[(Propylamino)carbonyl]oxiran-2-Yl}carbonyl)-L-Isoleucyl-L-Prolinate

N2-{1-[2-(methoxycarbonyl)pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl}-N3-propyloxirane-2,3-dicarboximidate

C19H31N3O6 (397.2213)


   

6-[[3-Fluoro-5-(4-methoxyoxan-4-yl)phenoxy]methyl]-1-methylquinolin-2-one

6-((3-Fluoro-5-(4-methoxy-3,4,5,6-tetrahydro-2H-pyran-4-yl)phenoxy)methyl)-1-methylquinol-2-one

C23H24FNO4 (397.1689)


   

Reduced ketanserin

3-(2-{4-[(4-fluorophenyl)(hydroxy)methyl]piperidin-1-yl}ethyl)-1,2,3,4-tetrahydroquinazoline-2,4-dione

C22H24FN3O3 (397.1802)


   

N-Acetyl-9-aminominocycline, (4R)-

6-[3-[1-(Dimethylamino)-2-methylpentan-3-yl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C20H31NO7 (397.21)


   
   

Echihumiline

Echihumiline

C20H31NO7 (397.21)


   
   

Vilmorrianone

Vilmorrianone

C23H27NO5 (397.1889)


A natural product found in Aconitum vilmorinianum and Delphinium denudatum.

   
   
   

Cyclomarazine A

Cyclomarazine A

C23H31N3O3 (397.2365)


   

methyl 2-[1-(4-fluorobenzyl)-1h-indazole-3-carboxamido]-3,3-dimethylbutanoate

methyl 2-[1-(4-fluorobenzyl)-1h-indazole-3-carboxamido]-3,3-dimethylbutanoate

C22H24FN3O3 (397.1802)


   
   
   
   
   
   
   

Gly-Pro-Ala-Gly-Pro

Gly-Pro-Ala-Gly-Pro

C17H27N5O6 (397.1961)


   

Aspochalasin A

Aspochalasin A

C24H31NO4 (397.2253)


   
   

octadeca-9,12,15-trienoylanthranilic acid

octadeca-9,12,15-trienoylanthranilic acid

C25H35NO3 (397.2617)


   

(2E,12E)-pipertridecadienamide

(2E,12E)-pipertridecadienamide

C25H35NO3 (397.2617)


   

sarcodifurine B

sarcodifurine B

C23H27NO5 (397.1889)


   

neolamarckine A

neolamarckine A

C22H27N3O4 (397.2001)


   

15-acetyloxysongoramine|15-Acetylsongoramine

15-acetyloxysongoramine|15-Acetylsongoramine

C24H31NO4 (397.2253)


   

2,3-Epoxyechiumine

2,3-Epoxyechiumine

C20H31NO7 (397.21)


   

sarcodifurine A

sarcodifurine A

C23H27NO5 (397.1889)


   
   

histidylasparagyllysine

histidylasparagyllysine

C16H27N7O5 (397.2074)


   
   
   
   
   
   
   
   
   
   

asparagylhistidyllysine

asparagylhistidyllysine

C16H27N7O5 (397.2074)


   
   

(±)14(15)-EET-SI

(±)14(15)-EET-SI

C21H35NO4S (397.2287)


   
   
   
   
   
   
   
   

AT-56

4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine

C25H27N5 (397.2266)


   
   
   
   
   
   
   
   
   
   

dihydroprecondylocarpine acetate

dihydroprecondylocarpine acetate

C23H29N2O4+ (397.2127)


An organic cation which is an intermediate in the biosynthetic pathway leading to the synthesis of the monoterpenoid indole alkaloids, catharanthine and tabersonine.

   

Heliosupin

(1S,7aR)-7-[({(2S)-2,3-dihydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoyl}oxy)methyl]-2,3,5,7a-tetrahydro-1H-pyrrolo[1,2-a]pyrrol-1-yl (2Z)-2-methylbut-2-enoate

C20H31NO7 (397.21)


Heliosupine is an azabicycloalkane compound having angelyloxy and echimidinyloxymethyl substituents attached to the ring system. It is an azabicycloalkane, a diester and a 2-methylbut-2-enoic acid. It is functionally related to an angelic acid and an isocrotonic acid. Heliosupine is a natural product found in Cynoglossum australe, Paracaryum rugulosum, and other organisms with data available. See also: Comfrey Leaf (part of); Comfrey Root (part of). An azabicycloalkane compound having angelyloxy and echimidinyloxymethyl substituents attached to the ring system.

   
   

C19H27NO8_2-(4,5-Dihydroxy-7,7a-dimethyl-2-oxo-4,5,6,7,7a,7b-hexahydronaphtho[1,2-b]oxiren-1a(2H)-yl)-2-propen-1-yl 4-amino-2,3-dihydroxybutanoate

NCGC00381157-01_C19H27NO8_2-(4,5-Dihydroxy-7,7a-dimethyl-2-oxo-4,5,6,7,7a,7b-hexahydronaphtho[1,2-b]oxiren-1a(2H)-yl)-2-propen-1-yl 4-amino-2,3-dihydroxybutanoate

C19H27NO8 (397.1737)


   
   
   

Mycofactocinol-1

Mycofactocinol-1

C19H27NO8 (397.1737)


   

Phytosphingosine-1-P

Phytosphingosine-1-P

C18H40NO6P (397.2593)


   

Ala Gly His Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C15H23N7O6 (397.171)


   

Ala Gly Asn His

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C15H23N7O6 (397.171)


   

Ala His Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-carbamoylpropanoic acid

C15H23N7O6 (397.171)


   

Ala His Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]acetic acid

C15H23N7O6 (397.171)


   

Ala Asn Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C15H23N7O6 (397.171)


   

Ala Asn His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C15H23N7O6 (397.171)


   

Ala Asn Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Ala Pro Asn Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Ala Pro Pro Asn

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H27N5O6 (397.1961)


   

Gly Ala His Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C15H23N7O6 (397.171)


   

Gly Ala Asn His

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C15H23N7O6 (397.171)


   

Gly Gly His Lys

(2S)-6-amino-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C16H27N7O5 (397.2074)


   

Gly Gly His Gln

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C15H23N7O6 (397.171)


   

Gly Gly Lys His

(2S)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H27N7O5 (397.2074)


   

Gly Gly Gln His

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C15H23N7O6 (397.171)


   

Gly His Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-carbamoylpropanoic acid

C15H23N7O6 (397.171)


   

Gly His Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]acetamido}hexanoic acid

C16H27N7O5 (397.2074)


   

Gly His Gly Gln

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]acetamido}-4-carbamoylbutanoic acid

C15H23N7O6 (397.171)


   

Gly His Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]hexanamido]acetic acid

C16H27N7O5 (397.2074)


   

Gly His Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]propanoic acid

C15H23N7O6 (397.171)


   

Gly His Gln Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]acetic acid

C15H23N7O6 (397.171)


   

Gly Lys Gly His

(2S)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C16H27N7O5 (397.2074)


   

Gly Lys His Gly

2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C16H27N7O5 (397.2074)


   

Gly Lys Pro Pro

(2S)-1-{[(2S)-1-[(2S)-6-amino-2-(2-aminoacetamido)hexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C18H31N5O5 (397.2325)


   

Gly Asn Ala His

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C15H23N7O6 (397.171)


   

Gly Asn His Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C15H23N7O6 (397.171)


   

Gly Pro Lys Pro

(2S)-1-[(2S)-6-amino-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}hexanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O5 (397.2325)


   

Gly Pro Pro Lys

(2S)-6-amino-2-{[(2S)-1-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanoic acid

C18H31N5O5 (397.2325)


   

Gly Pro Pro Gln

(2S)-2-{[(2S)-1-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C17H27N5O6 (397.1961)


   

Gly Pro Gln Pro

(2S)-1-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Gly Gln Gly His

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C15H23N7O6 (397.171)


   

Gly Gln His Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C15H23N7O6 (397.171)


   

Gly Gln Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

His Ala Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]acetamido}-3-carbamoylpropanoic acid

C15H23N7O6 (397.171)


   

His Ala Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-carbamoylpropanamido]acetic acid

C15H23N7O6 (397.171)


   

His Gly Ala Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}propanamido]-3-carbamoylpropanoic acid

C15H23N7O6 (397.171)


   

His Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}acetamido)hexanoic acid

C16H27N7O5 (397.2074)


   

His Gly Gly Gln

(2S)-2-(2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}acetamido)-4-carbamoylbutanoic acid

C15H23N7O6 (397.171)


   

His Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}hexanamido]acetic acid

C16H27N7O5 (397.2074)


   

His Gly Asn Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-carbamoylpropanamido]propanoic acid

C15H23N7O6 (397.171)


   

His Gly Gln Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-4-carbamoylbutanamido]acetic acid

C15H23N7O6 (397.171)


   

His Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]acetamido}acetic acid

C16H27N7O5 (397.2074)


   

His Asn Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]propanamido]acetic acid

C15H23N7O6 (397.171)


   

His Asn Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]acetamido}propanoic acid

C15H23N7O6 (397.171)


   

His Gln Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]acetamido}acetic acid

C15H23N7O6 (397.171)


   
   
   
   
   
   
   

Lys Gly Gly His

(2S)-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)-3-(1H-imidazol-4-yl)propanoic acid

C16H27N7O5 (397.2074)


   

Lys Gly His Gly

2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]acetic acid

C16H27N7O5 (397.2074)


   

Lys Gly Pro Pro

(2S)-1-{[(2S)-1-{2-[(2S)-2,6-diaminohexanamido]acetyl}pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C18H31N5O5 (397.2325)


   

Lys His Gly Gly

2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}acetic acid

C16H27N7O5 (397.2074)


   

Lys Pro Gly Pro

(2S)-1-(2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}acetyl)pyrrolidine-2-carboxylic acid

C18H31N5O5 (397.2325)


   

Lys Pro Pro Gly

2-{[(2S)-1-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}acetic acid

C18H31N5O5 (397.2325)


   
   
   
   
   
   
   
   
   

Asn Ala Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C15H23N7O6 (397.171)


   

Asn Ala His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C15H23N7O6 (397.171)


   

Asn Ala Pro Pro

(2S)-1-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Asn Gly Ala His

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C15H23N7O6 (397.171)


   

Asn Gly His Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C15H23N7O6 (397.171)


   

Asn His Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]acetic acid

C15H23N7O6 (397.171)


   

Asn His Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}propanoic acid

C15H23N7O6 (397.171)


   

Asn Pro Ala Pro

(2S)-1-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Asn Pro Pro Ala

(2S)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanoic acid

C17H27N5O6 (397.1961)


   

Pro Ala Asn Pro

(2S)-1-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Pro Ala Pro Asn

(2S)-3-carbamoyl-2-{[(2S)-1-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C17H27N5O6 (397.1961)


   
   

Pro Gly Lys Pro

(2S)-1-[(2S)-6-amino-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}hexanoyl]pyrrolidine-2-carboxylic acid

C18H31N5O5 (397.2325)


   

Pro Gly Pro Lys

(2S)-6-amino-2-{[(2S)-1-{2-[(2S)-pyrrolidin-2-ylformamido]acetyl}pyrrolidin-2-yl]formamido}hexanoic acid

C18H31N5O5 (397.2325)


   

Pro Gly Pro Gln

(2S)-4-carbamoyl-2-{[(2S)-1-{2-[(2S)-pyrrolidin-2-ylformamido]acetyl}pyrrolidin-2-yl]formamido}butanoic acid

C17H27N5O6 (397.1961)


   

Pro Gly Gln Pro

(2S)-1-[(2S)-4-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Diethylpropion(metabolite V-glucuronide)

Diethylpropion(metabolite V-glucuronide)

C19H27NO8 (397.1737)


   

Pro Lys Gly Pro

(2S)-1-{2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H31N5O5 (397.2325)


   

Pro Lys Pro Gly

2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H31N5O5 (397.2325)


   

Pro Asn Ala Pro

(2S)-1-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Pro Asn Pro Ala

(2S)-2-{[(2S)-1-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C17H27N5O6 (397.1961)


   

Pro Pro Ala Asn

(2S)-3-carbamoyl-2-[(2S)-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C17H27N5O6 (397.1961)


   

Pro Pro Gly Lys

(2S)-6-amino-2-(2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}acetamido)hexanoic acid

C18H31N5O5 (397.2325)


   

Pro Pro Gly Gln

(2S)-4-carbamoyl-2-(2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}acetamido)butanoic acid

C17H27N5O6 (397.1961)


   

Pro Pro Lys Gly

2-[(2S)-6-amino-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}hexanamido]acetic acid

C18H31N5O5 (397.2325)


   

Pro Pro Asn Ala

(2S)-2-[(2S)-3-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C17H27N5O6 (397.1961)


   

Pro Pro Gln Gly

2-[(2S)-4-carbamoyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]acetic acid

C17H27N5O6 (397.1961)


   

Pro Gln Gly Pro

(2S)-1-{2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Pro Gln Pro Gly

2-{[(2S)-1-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H27N5O6 (397.1961)


   
   
   
   

Gln Gly Gly His

(2S)-2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)-3-(1H-imidazol-4-yl)propanoic acid

C15H23N7O6 (397.171)


   

Gln Gly His Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]acetic acid

C15H23N7O6 (397.171)


   

Gln Gly Pro Pro

(2S)-1-{[(2S)-1-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetyl}pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Gln His Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}acetic acid

C15H23N7O6 (397.171)


   
   

Gln Pro Gly Pro

(2S)-1-(2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetyl)pyrrolidine-2-carboxylic acid

C17H27N5O6 (397.1961)


   

Gln Pro Pro Gly

2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}acetic acid

C17H27N5O6 (397.1961)


   
   
   
   
   
   
   
   
   

Dibutanoyllecithin

Choline, hydroxide, dihydrogen phosphate, inner salt, ester with 1,2-dibutyrin, L-

C16H32NO8P (397.1865)


   

Dibutyroyl lecithin

3,5,9-Trioxa-4-phosphatridecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-(1-oxobutoxy)-, inner salt, 4-oxide

C16H32NO8P (397.1865)


   

PC(O-9:0/O-1:0)[U]

3,5,9-Trioxa-4-phosphaoctadecan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, inner salt, 4-oxide

C18H40NO6P (397.2593)


   

PC(9:0/0:0)

3,5,9-Trioxa-4-phosphaoctadecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-

C17H36NO7P (397.2229)


   

PC(9:0/0:0)[U]

3,5,9-Trioxa-4-phosphaoctadecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide

C17H36NO7P (397.2229)


   

PC(0:0/9:0)[U]

3,5,8-Trioxa-4-phosphaheptadecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide

C17H36NO7P (397.2229)


   

PE(12:0/0:0)

Dodecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-hydroxypropyl ester, (R)-

C17H36NO7P (397.2229)


   

(±)14(15)-EET-SI

N-(methylsulfonyl)-13-(3-pentyloxiranyl)-5Z,8Z,11Z-tridecatrienamide

C21H35NO4S (397.2287)


   

S32826

P-[[4-[(1-oxotetradecyl)amino]phenyl]methyl]-phosphonic acid

C21H36NO4P (397.2382)


   

PhS1P

(2S,3S,4R)-2-amino-3,4-dihydroxyoctadecyl dihydrogen phosphate

C18H40NO6P (397.2593)


   

PHS-1-Phosphate

Phytosphingosine-1-P

C18H40NO6P (397.2593)


   

Drotaverin

(1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline

C24H31NO4 (397.2253)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AD - Papaverine and derivatives C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   
   

bisdeallyalmitrine

bisdeallyalmitrine

C20H21F2N7 (397.1826)


   
   

PC 8:0

1,2-dibutyryl-sn-glycero-3-phosphocholine

C16H32NO8P (397.1865)


   

LPC 9:0

1-nonanoyl-sn-glycero-3-phosphocholine

C17H36NO7P (397.2229)


   

LPE 12:0

Dodecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-hydroxypropyl ester, (R)-

C17H36NO7P (397.2229)


   

Bz-Arg-4-Abz-OH hydrochloride salt

Bz-Arg-4-Abz-OH hydrochloride salt

C20H23N5O4 (397.175)


   
   

A-443654

(2s)-1-(1h-Indol-3-Yl)-3-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}propan-2-Amine

C24H23N5O (397.1903)


A-443654 is a pan-Akt inhibitor and has equal potency against Akt1, Akt2, or Akt3 within cells (Ki=160 pM)[1].

   

diperodon

diperodon

C22H27N3O4 (397.2001)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

1-[3-(9,9-dimethylfluoren-2-yl)phenyl]isoquinoline

1-[3-(9,9-dimethylfluoren-2-yl)phenyl]isoquinoline

C30H23N (397.183)


   

[(1S)-1-(5-Fluoro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)propyl]carbamic acid 1,1-dimethylethyl ester

[(1S)-1-(5-Fluoro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)propyl]carbamic acid 1,1-dimethylethyl ester

C22H24FN3O3 (397.1802)


   

3-N-BOC-AMINO-1-[2-AMINO-1-(3-PHENOXY-PHENYL)-ETHYL]-PYRROLIDINE

3-N-BOC-AMINO-1-[2-AMINO-1-(3-PHENOXY-PHENYL)-ETHYL]-PYRROLIDINE

C23H31N3O3 (397.2365)


   

4-(9H-fluoren-9-ylmethoxycarbonylamino)-2-[(2-methylpropan-2-yl)oxy]butanoic acid

4-(9H-fluoren-9-ylmethoxycarbonylamino)-2-[(2-methylpropan-2-yl)oxy]butanoic acid

C23H27NO5 (397.1889)


   

CA-074 methyl ester

Methyl N-({(2s,3s)-3-[(Propylamino)carbonyl]oxiran-2-Yl}carbonyl)-L-Isoleucyl-L-Prolinate

C19H31N3O6 (397.2213)


   

3-(2,2-diphenylethyl)-5-(2-piperidin-1-ylethyl)-1,2,4-oxadiazole,hydrochloride

3-(2,2-diphenylethyl)-5-(2-piperidin-1-ylethyl)-1,2,4-oxadiazole,hydrochloride

C23H28ClN3O (397.1921)


   

N-(4-Biphenylyl)-N-phenyl-4-biphenylamine

N-(4-Biphenylyl)-N-phenyl-4-biphenylamine

C30H23N (397.183)


   
   

H-His(Trt)-OH

H-His(Trt)-OH

C25H23N3O2 (397.179)


   

H-D-His(Trt)-OH

H-D-His(Trt)-OH

C25H23N3O2 (397.179)


   
   

Diethylamino hydroxybenzoyl hexyl benzoate

Diethylamino hydroxybenzoyl hexyl benzoate

C24H31NO4 (397.2253)


   

4-[2,6-bis(2,4-dimethylphenyl)-1H-1,3,5-triazin-4-ylidene]-3-hydroxycyclohexa-2,5-dien-1-one

4-[2,6-bis(2,4-dimethylphenyl)-1H-1,3,5-triazin-4-ylidene]-3-hydroxycyclohexa-2,5-dien-1-one

C25H23N3O2 (397.179)


   

(-)-Butaclamol Hydrochloride

(-)-Butaclamol Hydrochloride

C25H32ClNO (397.2172)


   

1-[(2-methylpropan-2-yl)oxycarbonyl]-4-(4-phenylmethoxyphenyl)pyrrolidine-3-carboxylic acid

1-[(2-methylpropan-2-yl)oxycarbonyl]-4-(4-phenylmethoxyphenyl)pyrrolidine-3-carboxylic acid

C23H27NO5 (397.1889)


   

(+)-Butaclamol Hydrochloride

(+)-Butaclamol Hydrochloride

C25H32ClNO (397.2172)


   

Fmoc-D-Allo-Thr(tBu)-OH

Fmoc-D-Allo-Thr(tBu)-OH

C23H27NO5 (397.1889)


   

4-(2-(BENZYL(METHYL)AMINO)ETHYL)-1,2-PHENYLENE BIS(2-METHYLPROPANOATE)

4-(2-(BENZYL(METHYL)AMINO)ETHYL)-1,2-PHENYLENE BIS(2-METHYLPROPANOATE)

C24H31NO4 (397.2253)


   

Fmoc-Thr(tBu)-OH

Fmoc-Thr(tBu)-OH

C23H27NO5 (397.1889)


   

Sodium N-tetradecanoyl-L-phenlyalaninate

Sodium N-tetradecanoyl-L-phenlyalaninate

C23H36NNaO3 (397.2593)


   

2 6-bis[(4s 5s)-4-methyl-5-phenyl-2-oxa&

2 6-bis[(4s 5s)-4-methyl-5-phenyl-2-oxa&

C25H23N3O2 (397.179)


   

cobalt cyclohexanebutyrate

cobalt cyclohexanebutyrate

C20H34CoO4 (397.1789)


   

Fmoc-N-Me-Ser(tBu)-OH

Fmoc-N-Me-Ser(tBu)-OH

C23H27NO5 (397.1889)


   

4-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]butanoic acid

4-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]butanoic acid

C23H27NO5 (397.1889)


   

FMOC-(3S,4S, 5S)-4-AMINO-3-HYDROXY-5-METHYL HEPTANOIC ACID

FMOC-(3S,4S, 5S)-4-AMINO-3-HYDROXY-5-METHYL HEPTANOIC ACID

C23H27NO5 (397.1889)


   

Fmoc-l-beta-homoserine(otbu)

Fmoc-l-beta-homoserine(otbu)

C23H27NO5 (397.1889)


   

Fmoc-Thr-OtBu

Fmoc-Thr-OtBu

C23H27NO5 (397.1889)


   

6,7-dimethoxy-1-(3,4,5-triethoxyphenyl)isoquinoline

6,7-dimethoxy-1-(3,4,5-triethoxyphenyl)isoquinoline

C23H27NO5 (397.1889)


   

2,6-bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)pyridine

2,6-bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)pyridine

C25H23N3O2 (397.179)


   

N-([1,1-biphenyl]-4-yl)-[1,1:4,1-terphenyl]-4-amine

N-([1,1-biphenyl]-4-yl)-[1,1:4,1-terphenyl]-4-amine

C30H23N (397.183)


   

Prochlorperazine Sulfoxide

Prochlorperazine Sulfoxide

C20H16ClD8N3OS (397.1831)


   

ETHYL 5-((7-ETHOXY-7-OXOHEPTYL)OXY)-4-METHOXY-2-NITROBENZOATE

ETHYL 5-((7-ETHOXY-7-OXOHEPTYL)OXY)-4-METHOXY-2-NITROBENZOATE

C19H27NO8 (397.1737)


   

2 6-BIS[(4R 5R)-4-METHYL-5-PHENYL-2-OXA&

2 6-BIS[(4R 5R)-4-METHYL-5-PHENYL-2-OXA&

C25H23N3O2 (397.179)


   

Fmoc-Allo-Thr(tBu)-OH

Fmoc-Allo-Thr(tBu)-OH

C23H27NO5 (397.1889)


   

manganese neodecanoate

manganese neodecanoate

C20H38MnO4 (397.215)


   

Butanoic acid, 3-(1,1-dimethylethoxy)-4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (3S)

Butanoic acid, 3-(1,1-dimethylethoxy)-4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (3S)

C23H27NO5 (397.1889)


   

Fmoc-O-tert-butyl-D-threonine

Fmoc-O-tert-butyl-D-threonine

C23H27NO5 (397.1889)


   

Cobalt Naphthenate

Cobalt Naphthenate

C20H34CoO4 (397.1789)


   

Cc-223

Cc-223

C21H27N5O3 (397.2114)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Onatasertib (CC-223) is a potent, selective, and orally bioavailable inhibitor of mTOR kinase, with an IC50 value for mTOR kinase of 16 nM. Onatasertib inhibits both mTORC1 and mTORC2. Onatasertib (CC-223) is a potent, selective, and orally bioavailable inhibitor of mTOR kinase, with an IC50 value for mTOR kinase of 16 nM. Onatasertib inhibits both mTORC1 and mTORC2.

   

Fadraciclib

Fadraciclib

C21H31N7O (397.259)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   

3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one

3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one

C24H23N5O (397.1903)


   

Platensimycin B3

Platensimycin B3

C23H27NO5 (397.1889)


A polycyclic cage that is the decarboxy derivative of platensimycin. It is isolated from Streptomyces platensis.

   

N-Acetyl-9-aminominocycline, (4R)-

N-Acetyl-9-aminominocycline, (4R)-

C20H31NO7 (397.21)


   

2-[8-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-1,3-dimethyl-2,6-dioxo-7-purinyl]acetic acid methyl ester

2-[8-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-1,3-dimethyl-2,6-dioxo-7-purinyl]acetic acid methyl ester

C20H23N5O4 (397.175)


   

symphytine N-oxide

(3S,4S,4aR,6aR,6bS,8aS,12aR,14aR,14bR)-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,12,12a,14,14a-dodecahydropicen-3-ol

C20H31NO7 (397.21)


   
   

N-[[1-ethyl-6-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]methyl]-2-methylpyrazole-3-carboxamide

N-[[1-ethyl-6-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]methyl]-2-methylpyrazole-3-carboxamide

C20H27N7O2 (397.2226)


   

Dibutyroylphosphatidylcholine, dl-

Dibutyroylphosphatidylcholine, dl-

C16H32NO8P (397.1865)


   

(2S)-4-(2,5-Difluorophenyl)-N-methyl-2-phenyl-N-piperidin-4-YL-2,5-dihydro-1H-pyrrole-1-carboxamide

(2S)-4-(2,5-Difluorophenyl)-N-methyl-2-phenyl-N-piperidin-4-YL-2,5-dihydro-1H-pyrrole-1-carboxamide

C23H25F2N3O (397.1966)


   

2-{4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-D]pyrimidin-5-YL)-ethyl]-benzoylamino}-3-methyl-butyric acid

2-{4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-D]pyrimidin-5-YL)-ethyl]-benzoylamino}-3-methyl-butyric acid

C20H23N5O4 (397.175)


   

(Methylpyridazine piperidine butyloxyphenyl)ethylacetate

(Methylpyridazine piperidine butyloxyphenyl)ethylacetate

C23H31N3O3 (397.2365)


   

Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate

Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate

C18H28FN5O4 (397.2125)


   

Drotaverine

Drotaverin hydrochloride

C24H31NO4 (397.2253)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AD - Papaverine and derivatives C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Reduced ketanserin

3-(2-{4-[(4-fluorophenyl)(hydroxy)methyl]piperidin-1-yl}ethyl)-1,2,3,4-tetrahydroquinazoline-2,4-dione

C22H24FN3O3 (397.1802)


   

O-acetyl-15alpha-stemmadenine

O-acetyl-15alpha-stemmadenine

C23H29N2O4+ (397.2127)


   

1-Lauroyl-sn-glycero-3-phosphoethanolamine

1-Lauroyl-sn-glycero-3-phosphoethanolamine

C17H36NO7P (397.2229)


   

dihydroprecondylocarpine acetate (enamine form)

dihydroprecondylocarpine acetate (enamine form)

C23H29N2O4+ (397.2127)


   

2-acyl-sn-glycero-3-phosphoethanolamine (n-C12:0)

2-acyl-sn-glycero-3-phosphoethanolamine (n-C12:0)

C17H36NO7P (397.2229)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate

C17H36NO7P (397.2229)


   
   

Tetradeca-9,11-dienedioylcarnitine

Tetradeca-9,11-dienedioylcarnitine

C21H35NO6 (397.2464)


   

(6E,9E)-Tetradeca-6,9-dienedioylcarnitine

(6E,9E)-Tetradeca-6,9-dienedioylcarnitine

C21H35NO6 (397.2464)


   

(2E,4Z)-Tetradeca-2,4-dienedioylcarnitine

(2E,4Z)-Tetradeca-2,4-dienedioylcarnitine

C21H35NO6 (397.2464)


   

(2S)-1-[(2S)-3-methyl-1-oxo-2-[[oxo-[(2S,3S)-3-[oxo(propylamino)methyl]-2-oxiranyl]methyl]amino]pentyl]-2-pyrrolidinecarboxylic acid methyl ester

(2S)-1-[(2S)-3-methyl-1-oxo-2-[[oxo-[(2S,3S)-3-[oxo(propylamino)methyl]-2-oxiranyl]methyl]amino]pentyl]-2-pyrrolidinecarboxylic acid methyl ester

C19H31N3O6 (397.2213)


   
   

2-(4-Ethoxyphenyl)-3,4-dimethyl-7-[2-(1-pyrrolidinyl)ethylthio]pyrazolo[3,4-d]pyridazine

2-(4-Ethoxyphenyl)-3,4-dimethyl-7-[2-(1-pyrrolidinyl)ethylthio]pyrazolo[3,4-d]pyridazine

C21H27N5OS (397.1936)


   

2-[[4,6-Bis(1-piperidinyl)-1,3,5-triazin-2-yl]thio]-1-phenylethanone

2-[[4,6-Bis(1-piperidinyl)-1,3,5-triazin-2-yl]thio]-1-phenylethanone

C21H27N5OS (397.1936)


   

1-Decyl-sn-glycero-3-phosphocholine

1-Decyl-sn-glycero-3-phosphocholine

C18H40NO6P (397.2593)


   

2-[5-(3,4-diethoxyphenyl)-2-tetrazolyl]-N-(3-methoxyphenyl)acetamide

2-[5-(3,4-diethoxyphenyl)-2-tetrazolyl]-N-(3-methoxyphenyl)acetamide

C20H23N5O4 (397.175)


   

2-[4-(5-chloro-2-methylphenyl)-1-piperazinyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide

2-[4-(5-chloro-2-methylphenyl)-1-piperazinyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide

C23H28ClN3O (397.1921)


   

3-[2-Oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-1,3-diazaspiro[4.6]undecane-2,4-dione

3-[2-Oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-1,3-diazaspiro[4.6]undecane-2,4-dione

C23H31N3O3 (397.2365)


   

4-cinnamyl-N-(3,5-dimethoxyphenyl)-1-piperazinecarbothioamide

4-cinnamyl-N-(3,5-dimethoxyphenyl)-1-piperazinecarbothioamide

C22H27N3O2S (397.1824)


   

N-[2-(4-morpholinyl)ethyl]-4-(phenylmethyl)-2,3-dihydro-1,4-benzothiazine-6-carboxamide

N-[2-(4-morpholinyl)ethyl]-4-(phenylmethyl)-2,3-dihydro-1,4-benzothiazine-6-carboxamide

C22H27N3O2S (397.1824)


   

4-(2-Fluorophenyl)-1-[[1-[(4-methoxyphenyl)methyl]-5-tetrazolyl]methyl]-4-piperidinol

4-(2-Fluorophenyl)-1-[[1-[(4-methoxyphenyl)methyl]-5-tetrazolyl]methyl]-4-piperidinol

C21H24FN5O2 (397.1914)


   

5-amino-N-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2-methoxyphenyl)-4-triazolecarboxamide

5-amino-N-[2-(3,4-dimethoxyphenyl)ethyl]-1-(2-methoxyphenyl)-4-triazolecarboxamide

C20H23N5O4 (397.175)


   
   
   

N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

C18H31N5O5 (397.2325)


   

N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

C18H31N5O5 (397.2325)


   

N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

C18H31N5O5 (397.2325)


   

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

C18H31N5O5 (397.2325)


   

1-[2-[[(3,4-Difluoroanilino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester

1-[2-[[(3,4-Difluoroanilino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester

C19H25F2N3O4 (397.1813)


   
   
   
   

(+/-)14(15)-Eet-SI

(+/-)14(15)-Eet-SI

C21H35NO4S (397.2287)


   

N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

C18H31N5O5 (397.2325)


   

(3Z)-1-(4-benzoylpyridin-1-ium-1-yl)-3-(1,3,3-trimethylindol-2-ylidene)propan-2-one

(3Z)-1-(4-benzoylpyridin-1-ium-1-yl)-3-(1,3,3-trimethylindol-2-ylidene)propan-2-one

C26H25N2O2+ (397.1916)


   

N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

C18H31N5O5 (397.2325)


   

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]oxan-3-yl]pyridine-3-carboxamide

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]oxan-3-yl]pyridine-3-carboxamide

C22H27N3O4 (397.2001)


   

2-[(1S,3S,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

2-[(1S,3S,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C22H27N3O4 (397.2001)


   

2-[(1R,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

2-[(1R,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C22H27N3O4 (397.2001)


   

(3aR,6aS)-4-methylsulfonyl-1-[(E)-4-piperidin-1-ylbut-2-enoyl]-6-propan-2-yl-3,3a,6,6a-tetrahydro-2H-pyrrolo[3,2-b]pyrrol-5-one

(3aR,6aS)-4-methylsulfonyl-1-[(E)-4-piperidin-1-ylbut-2-enoyl]-6-propan-2-yl-3,3a,6,6a-tetrahydro-2H-pyrrolo[3,2-b]pyrrol-5-one

C19H31N3O4S (397.2035)


   

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

C18H31N5O5 (397.2325)


   

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]oxan-3-yl]pyridine-3-carboxamide

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]oxan-3-yl]pyridine-3-carboxamide

C22H27N3O4 (397.2001)


   

2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C22H27N3O4 (397.2001)


   

2-[(1S,3S,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

2-[(1S,3S,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C22H27N3O4 (397.2001)


   

N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcarbamic acid methyl ester

C18H31N5O5 (397.2325)


   

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-cyclohexyl-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-cyclohexyl-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C20H35N3O5 (397.2577)


   

N-cyclohexyl-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-cyclohexyl-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C20H35N3O5 (397.2577)


   

2-[(1R,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

2-[(1R,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C22H27N3O4 (397.2001)


   

N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-2-azetidinyl]methyl]-2-methoxy-N-methylacetamide

N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-2-azetidinyl]methyl]-2-methoxy-N-methylacetamide

C22H27N3O4 (397.2001)


   

2-(dimethylamino)-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

2-(dimethylamino)-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

C19H31N3O4S (397.2035)


   

2-(dimethylamino)-N-[[(2R,3R,4R)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

2-(dimethylamino)-N-[[(2R,3R,4R)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

C19H31N3O4S (397.2035)


   

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methoxyethyl)-3-pyridinecarboxamide

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methoxyethyl)-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methoxyethyl)-3-pyridinecarboxamide

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methoxyethyl)-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

(1R,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-4-(1-oxobutyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-4-(1-oxobutyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C22H24FN3O3 (397.1802)


   

(1S,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-4-(1-oxobutyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-4-(1-oxobutyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C22H24FN3O3 (397.1802)


   

(2S,3S)-1-acetyl-3-[4-(1-cyclopentenyl)phenyl]-2-(hydroxymethyl)-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-6-carboxamide

(2S,3S)-1-acetyl-3-[4-(1-cyclopentenyl)phenyl]-2-(hydroxymethyl)-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-6-carboxamide

C23H31N3O3 (397.2365)


   

(2R,3R)-6-[cyclobutyl(oxo)methyl]-N-cyclopentyl-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2R,3R)-6-[cyclobutyl(oxo)methyl]-N-cyclopentyl-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C23H31N3O3 (397.2365)


   

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[[(1R)-1-phenylethyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-cyclohexyl-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-cyclohexyl-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C20H35N3O5 (397.2577)


   

N-cyclohexyl-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-cyclohexyl-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C20H35N3O5 (397.2577)


   

N-cyclohexyl-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-cyclohexyl-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C20H35N3O5 (397.2577)


   

N-cyclohexyl-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-cyclohexyl-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C20H35N3O5 (397.2577)


   

N-cyclohexyl-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-cyclohexyl-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C20H35N3O5 (397.2577)


   

N-cyclohexyl-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

N-cyclohexyl-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]acetamide

C20H35N3O5 (397.2577)


   

2-[(1R,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

2-[(1R,3R,4aR,9aS)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C22H27N3O4 (397.2001)


   

2-[(1R,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

2-[(1R,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C22H27N3O4 (397.2001)


   

2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C22H27N3O4 (397.2001)


   

N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-2-azetidinyl]methyl]-2-methoxy-N-methylacetamide

N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-2-azetidinyl]methyl]-2-methoxy-N-methylacetamide

C22H27N3O4 (397.2001)


   

N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-2-azetidinyl]methyl]-2-methoxy-N-methylacetamide

N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-[1-oxo-2-(3-pyridinyl)ethyl]-3-phenyl-2-azetidinyl]methyl]-2-methoxy-N-methylacetamide

C22H27N3O4 (397.2001)


   

2-(dimethylamino)-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

2-(dimethylamino)-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

C19H31N3O4S (397.2035)


   

2-(dimethylamino)-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

2-(dimethylamino)-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

C19H31N3O4S (397.2035)


   

2-(dimethylamino)-N-[[(2S,3S,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

2-(dimethylamino)-N-[[(2S,3S,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

C19H31N3O4S (397.2035)


   

2-(dimethylamino)-N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

2-(dimethylamino)-N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]-N-propan-2-ylacetamide

C19H31N3O4S (397.2035)


   

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methoxyethyl)-3-pyridinecarboxamide

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methoxyethyl)-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

N-[[(2S,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methoxyethyl)-3-pyridinecarboxamide

N-[[(2S,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-N-(2-methoxyethyl)-3-pyridinecarboxamide

C22H27N3O4 (397.2001)


   

[(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(4,5-dimethyl-2-thiazolyl)-4-(ethylaminomethyl)-2-azetidinyl]methanol

[(2R,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(4,5-dimethyl-2-thiazolyl)-4-(ethylaminomethyl)-2-azetidinyl]methanol

C23H31N3OS (397.2188)


   

(1R,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-4-(1-oxobutyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-4-(1-oxobutyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C22H24FN3O3 (397.1802)


   

(1S,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-4-(1-oxobutyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-4-(1-oxobutyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C22H24FN3O3 (397.1802)


   

(2R,3R)-1-acetyl-3-[4-(1-cyclopentenyl)phenyl]-2-(hydroxymethyl)-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-6-carboxamide

(2R,3R)-1-acetyl-3-[4-(1-cyclopentenyl)phenyl]-2-(hydroxymethyl)-N-propan-2-yl-1,6-diazaspiro[3.3]heptane-6-carboxamide

C23H31N3O3 (397.2365)


   

1-[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

1-[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

C23H31N3O3 (397.2365)


   

(6R,7R,8S)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8S)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H31N3O3 (397.2365)


   

(6R,7R,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-prop-1-enyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C23H31N3O3 (397.2365)


   

(2S,3S)-6-[cyclobutyl(oxo)methyl]-N-cyclopentyl-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2S,3S)-6-[cyclobutyl(oxo)methyl]-N-cyclopentyl-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C23H31N3O3 (397.2365)


   

Tridihexethyl bromide

Tridihexethyl bromide

C21H36BrNO (397.198)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Beraprost anion

Beraprost anion

C24H29O5- (397.2015)


   

(beta-D-glucosyl)-O-mycofactocinol

(beta-D-glucosyl)-O-mycofactocinol

C19H27NO8 (397.1737)


   

7,7-Dimethyl-10-(4-propan-2-ylphenyl)-6,8,10,10a-tetrahydroindeno[1,2-b]quinoline-9,11-dione

7,7-Dimethyl-10-(4-propan-2-ylphenyl)-6,8,10,10a-tetrahydroindeno[1,2-b]quinoline-9,11-dione

C27H27NO2 (397.2042)


   

2-(3,4-dimethylphenyl)-N-[(E)-(1,5-dimethyl-1H-pyrazol-4-yl)methylidene]quinoline-4-carbohydrazide

2-(3,4-dimethylphenyl)-N-[(E)-(1,5-dimethyl-1H-pyrazol-4-yl)methylidene]quinoline-4-carbohydrazide

C24H23N5O (397.1903)


   

(4S)-6-chloro-2-methyl-4-(4-methylphenyl)-3-(2-piperidin-1-ylethyl)quinazolin-4-ol

(4S)-6-chloro-2-methyl-4-(4-methylphenyl)-3-(2-piperidin-1-ylethyl)quinazolin-4-ol

C23H28ClN3O (397.1921)


   

(3-Decoxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decoxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C18H40NO6P (397.2593)


   

1-Nonanoyl-2-hydroxy-sn-glycero-3-phosphocholine

1-Nonanoyl-2-hydroxy-sn-glycero-3-phosphocholine

C17H36NO7P (397.2229)


   

2-Aminoethyl (2-hydroxy-3-tridecoxypropyl) hydrogen phosphate

2-Aminoethyl (2-hydroxy-3-tridecoxypropyl) hydrogen phosphate

C18H40NO6P (397.2593)


   

Lnape 7:0/N-4:0

Lnape 7:0/N-4:0

C16H32NO8P (397.1865)


   

Lnape 9:0/N-2:0

Lnape 9:0/N-2:0

C16H32NO8P (397.1865)


   

Lnape 4:0/N-7:0

Lnape 4:0/N-7:0

C16H32NO8P (397.1865)


   

Lnape 3:0/N-8:0

Lnape 3:0/N-8:0

C16H32NO8P (397.1865)


   

Lnape 6:0/N-5:0

Lnape 6:0/N-5:0

C16H32NO8P (397.1865)


   

Lnape 2:0/N-9:0

Lnape 2:0/N-9:0

C16H32NO8P (397.1865)


   

Lnape 8:0/N-3:0

Lnape 8:0/N-3:0

C16H32NO8P (397.1865)


   

Lnape 5:0/N-6:0

Lnape 5:0/N-6:0

C16H32NO8P (397.1865)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] dodecanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] dodecanoate

C17H36NO7P (397.2229)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] butanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] butanoate

C17H36NO7P (397.2229)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] propanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] propanoate

C17H36NO7P (397.2229)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] acetate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] acetate

C17H36NO7P (397.2229)


   

N-[[(3,4-Dihydro-6-methoxy-2,5,7,8-tetramethyl-2H-1-benzopyran)-2-yl]acetyl]anthanilic acid

N-[[(3,4-Dihydro-6-methoxy-2,5,7,8-tetramethyl-2H-1-benzopyran)-2-yl]acetyl]anthanilic acid

C23H27NO5 (397.1889)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] octanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] octanoate

C16H32NO8P (397.1865)


   

(2-Pentanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Pentanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C16H32NO8P (397.1865)


   

(3-Acetyloxy-2-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Acetyloxy-2-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C16H32NO8P (397.1865)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] heptanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] heptanoate

C16H32NO8P (397.1865)


   

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] nonanoate

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] nonanoate

C16H32NO8P (397.1865)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] hexanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] hexanoate

C16H32NO8P (397.1865)


   

2-[(2-Acetamido-3-hydroxydecoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Acetamido-3-hydroxydecoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C17H38N2O6P+ (397.2467)


   

2-[[2-(Butanoylamino)-3-hydroxyoctoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-(Butanoylamino)-3-hydroxyoctoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C17H38N2O6P+ (397.2467)


   

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)nonoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)nonoxy]phosphoryl]oxyethyl-trimethylazanium

C17H38N2O6P+ (397.2467)


   

Phytosphingosine 1-phosphate

Phytosphingosine 1-phosphate

C18H40NO6P (397.2593)


A phosphosphingolipid that is phytosphingosine bearing a phospho group at position 1.

   

1-dodecanoyl-sn-glycero-3-phosphoethanolamine

1-dodecanoyl-sn-glycero-3-phosphoethanolamine

C17H36NO7P (397.2229)


   

O-acetyl-15alpha-stemmadenine(1+)

O-acetyl-15alpha-stemmadenine(1+)

C23H29N2O4 (397.2127)


An ammonium ion resulting from the protonation of the tertiary amino group of O-acetyl-15alpha-stemmadenine. The major species at pH 7.3.

   

4-Tetradecanamidobenzylphosphonic acid

4-Tetradecanamidobenzylphosphonic acid

C21H36NO4P (397.2382)


   

1-nonanoyl-sn-glycero-3-phosphocholine

1-nonanoyl-sn-glycero-3-phosphocholine

C17H36NO7P (397.2229)


   

1,2-dibutyryl-sn-glycero-3-phosphocholine

1,2-dibutyryl-sn-glycero-3-phosphocholine

C16H32NO8P (397.1865)


   

symphytine oxide

symphytine oxide

C20H31NO7 (397.21)


A pyrrolizine that is the N-oxido derivative of symphytine. Isolated from extracts of comfrey root.

   

NA-PABA 18:3(6Z,9Z,12Z)

NA-PABA 18:3(6Z,9Z,12Z)

C25H35NO3 (397.2617)


   

NA-PABA 18:3(9Z,12Z,15Z)

NA-PABA 18:3(9Z,12Z,15Z)

C25H35NO3 (397.2617)


   
   
   
   
   
   

ST 18:1;O5;Gly

ST 18:1;O5;Gly

C20H31NO7 (397.21)


   

ST 19:0;O4;Gly

ST 19:0;O4;Gly

C21H35NO6 (397.2464)


   

ST 21:6;O3;Gly

ST 21:6;O3;Gly

C23H27NO5 (397.1889)


   

ST 22:5;O2;Gly

ST 22:5;O2;Gly

C24H31NO4 (397.2253)


   
   

N-Demethyl MK-6884

N-Demethyl MK-6884

C24H23N5O (397.1903)


N-Demethyl MK-6884 (compound 34) is a potent M4 mAChR allosteric modulator. N-Demethyl MK-6884 can be used in the studies of alzheimer's disease and other diseases mediated by the M4 mAChR[1].

   

(1r,7ar)-7-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-4-hydroxy-3-methylbut-2-enoate

(1r,7ar)-7-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-4-hydroxy-3-methylbut-2-enoate

C20H31NO7 (397.21)


   

13,15-dihydroxy-3,15-dimethyl-6-(6-methylhepta-3,5-dien-2-yl)-12-azatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadeca-7,9-dien-11-one

13,15-dihydroxy-3,15-dimethyl-6-(6-methylhepta-3,5-dien-2-yl)-12-azatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadeca-7,9-dien-11-one

C25H35NO3 (397.2617)


   

(1r,7ar)-7-({[(2s)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1r,7ar)-7-({[(2s)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C20H31NO7 (397.21)


   

(1s,12s,14s,15e)-15-ethylidene-13-(hydroxymethyl)-6-methoxy-13-(methoxycarbonyl)-17-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-17-ium

(1s,12s,14s,15e)-15-ethylidene-13-(hydroxymethyl)-6-methoxy-13-(methoxycarbonyl)-17-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-17-ium

[C23H29N2O4]+ (397.2127)


   

(3z,7z,9s,12r,14r)-12-hydroxy-14-[(2s)-2-hydroxy-2-[(4r)-2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl]ethyl]-4,9-dimethyl-1-oxacyclotetradeca-3,7-dien-2-one

(3z,7z,9s,12r,14r)-12-hydroxy-14-[(2s)-2-hydroxy-2-[(4r)-2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl]ethyl]-4,9-dimethyl-1-oxacyclotetradeca-3,7-dien-2-one

C20H31NO5S (397.1923)


   

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-isopropylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-4-hydroxy-3-methylbut-2-enoate

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-isopropylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-4-hydroxy-3-methylbut-2-enoate

C20H31NO7 (397.21)


   

(7r,7ar)-1-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

(7r,7ar)-1-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-7-{[(2e)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

C20H31NO7 (397.21)


   

(1r,7ar)-7-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate

(1r,7ar)-7-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate

C20H31NO7 (397.21)


   

(2s,4s,5r,7s)-2,5-diamino-4-hydroxy-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}octanedioic acid

(2s,4s,5r,7s)-2,5-diamino-4-hydroxy-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}octanedioic acid

C14H27N3O10 (397.1696)


   

8,16-dimethoxy-12,13,13-trimethyl-16-(3-methylbut-2-en-1-yl)-4,14-dioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(9),2,5,7,11(15)-pentaen-10-one

8,16-dimethoxy-12,13,13-trimethyl-16-(3-methylbut-2-en-1-yl)-4,14-dioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(9),2,5,7,11(15)-pentaen-10-one

C23H27NO5 (397.1889)


   

(3s,6s)-5-hydroxy-6-[(2r)-3-hydroxy-2-methylpropyl]-1-methyl-3-{[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-3,6-dihydropyrazin-2-one

(3s,6s)-5-hydroxy-6-[(2r)-3-hydroxy-2-methylpropyl]-1-methyl-3-{[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-3,6-dihydropyrazin-2-one

C23H31N3O3 (397.2365)


   

12-hydroxy-14-[2-hydroxy-2-(2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl)ethyl]-4,9-dimethyl-1-oxacyclotetradeca-3,7-dien-2-one

12-hydroxy-14-[2-hydroxy-2-(2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl)ethyl]-4,9-dimethyl-1-oxacyclotetradeca-3,7-dien-2-one

C20H31NO5S (397.1923)


   

(1s,7ar)-7-({[(2r)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1s,7ar)-7-({[(2r)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C20H31NO7 (397.21)


   

5,6,14,15-tetramethoxy-1-methyl-17-oxa-9-azapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-2,4,6,12,14,16(20)-hexaene

5,6,14,15-tetramethoxy-1-methyl-17-oxa-9-azapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-2,4,6,12,14,16(20)-hexaene

C23H27NO5 (397.1889)


   

(7r,7ar)-1-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

(7r,7ar)-1-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-7-{[(2z)-2-methylbut-2-enoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

C20H31NO7 (397.21)


   

11-hydroxy-7-methyl-17-methylidene-5-azahexacyclo[9.6.2.0³,¹⁵.0⁴,¹².0⁷,¹².0¹⁵,¹⁹]nonadec-4-en-14-yl 2-methylbutanoate

11-hydroxy-7-methyl-17-methylidene-5-azahexacyclo[9.6.2.0³,¹⁵.0⁴,¹².0⁷,¹².0¹⁵,¹⁹]nonadec-4-en-14-yl 2-methylbutanoate

C25H35NO3 (397.2617)


   

(1r)-3-hydroxy-4,5-dimethoxy-12',12'-dimethyl-4',6'-dioxa-12'-azaspiro[isoindole-1,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-1',3'(7'),8'-trien-12'-ium

(1r)-3-hydroxy-4,5-dimethoxy-12',12'-dimethyl-4',6'-dioxa-12'-azaspiro[isoindole-1,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-1',3'(7'),8'-trien-12'-ium

[C22H25N2O5]+ (397.1763)


   

methyl (1r,14r,15r,16s,20s)-14-(hydroxymethyl)-16-methoxy-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

methyl (1r,14r,15r,16s,20s)-14-(hydroxymethyl)-16-methoxy-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

C22H27N3O4 (397.2001)


   

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

C20H31NO7 (397.21)


   

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C20H31NO7 (397.21)


   

7-({[2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate

7-({[2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate

C20H31NO7 (397.21)


   

n-(2,6-dihydroxyphenyl)-3-{5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}propanimidic acid

n-(2,6-dihydroxyphenyl)-3-{5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}propanimidic acid

C23H27NO5 (397.1889)


   

methyl 14-(hydroxymethyl)-16-methoxy-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

methyl 14-(hydroxymethyl)-16-methoxy-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,18-pentaene-19-carboxylate

C22H27N3O4 (397.2001)


   

7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 4-hydroxy-3-methylbut-2-enoate

7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 4-hydroxy-3-methylbut-2-enoate

C20H31NO7 (397.21)


   

(1r,7ar)-7-({[(2s)-2,3-dihydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-2-methylbut-2-enoate

(1r,7ar)-7-({[(2s)-2,3-dihydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-2-methylbut-2-enoate

C20H31NO7 (397.21)


   

(1s,3r,6r,9e,13s,15r,16r)-3,15-dimethyl-6-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-12-azatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadeca-7,9,11-triene-11,13,15-triol

(1s,3r,6r,9e,13s,15r,16r)-3,15-dimethyl-6-[(2s,3z)-6-methylhepta-3,5-dien-2-yl]-12-azatetracyclo[8.5.1.0³,⁷.0¹³,¹⁶]hexadeca-7,9,11-triene-11,13,15-triol

C25H35NO3 (397.2617)


   

(12s,16s)-8,16-dimethoxy-12,13,13-trimethyl-16-(3-methylbut-2-en-1-yl)-4,14-dioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(9),2,5,7,11(15)-pentaen-10-one

(12s,16s)-8,16-dimethoxy-12,13,13-trimethyl-16-(3-methylbut-2-en-1-yl)-4,14-dioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(9),2,5,7,11(15)-pentaen-10-one

C23H27NO5 (397.1889)


   

(2r,3s,4as,4br,5's,7r,8as)-2'-hydroxy-5'-[(1r)-1-hydroxyethyl]-4a,7-dimethyl-2-(prop-1-en-1-yl)-4b,5,6,7,8,8a-hexahydro-2h,5'h-spiro[phenanthrene-3,3'-pyrrole]-4,4'-dione

(2r,3s,4as,4br,5's,7r,8as)-2'-hydroxy-5'-[(1r)-1-hydroxyethyl]-4a,7-dimethyl-2-(prop-1-en-1-yl)-4b,5,6,7,8,8a-hexahydro-2h,5'h-spiro[phenanthrene-3,3'-pyrrole]-4,4'-dione

C24H31NO4 (397.2253)


   

(3e,7e,9s,12s,14r)-12-hydroxy-14-[(2s)-2-hydroxy-2-[(4r)-2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl]ethyl]-4,9-dimethyl-1-oxacyclotetradeca-3,7-dien-2-one

(3e,7e,9s,12s,14r)-12-hydroxy-14-[(2s)-2-hydroxy-2-[(4r)-2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl]ethyl]-4,9-dimethyl-1-oxacyclotetradeca-3,7-dien-2-one

C20H31NO5S (397.1923)


   

n-{6-[(1,4-diamino-2,5,6-trihydroxyhexan-3-yl)oxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl}propanimidic acid

n-{6-[(1,4-diamino-2,5,6-trihydroxyhexan-3-yl)oxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl}propanimidic acid

C15H31N3O9 (397.206)


   

(1r,7ar)-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-4-hydroxy-3-methylbut-2-enoate

(1r,7ar)-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-4-hydroxy-3-methylbut-2-enoate

C20H31NO7 (397.21)


   

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-2-methylbut-2-enoate

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2e)-2-methylbut-2-enoate

C20H31NO7 (397.21)


   

(1s,3s,5r,8r,9s,11s,14r,17r,18s)-5,7-dimethyl-12-methylidene-10,15,16-trioxo-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl acetate

(1s,3s,5r,8r,9s,11s,14r,17r,18s)-5,7-dimethyl-12-methylidene-10,15,16-trioxo-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl acetate

C23H27NO5 (397.1889)


   

2,5-diamino-4-hydroxy-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}octanedioic acid

2,5-diamino-4-hydroxy-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}octanedioic acid

C14H27N3O10 (397.1696)


   

(5r,8r)-8,16-dimethoxy-4,4,5-trimethyl-8-(3-methylbut-2-en-1-yl)-3,12-dioxa-10-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1(9),2(6),10,13,15-pentaen-7-one

(5r,8r)-8,16-dimethoxy-4,4,5-trimethyl-8-(3-methylbut-2-en-1-yl)-3,12-dioxa-10-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1(9),2(6),10,13,15-pentaen-7-one

C23H27NO5 (397.1889)


   

7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2,3-dimethyloxirane-2-carboxylate

7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2,3-dimethyloxirane-2-carboxylate

C20H31NO7 (397.21)


   

(7r,7ar)-1-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-7-[(3-methylbut-2-enoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

(7r,7ar)-1-({[(2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-7-[(3-methylbut-2-enoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-4-ium-4-olate

C20H31NO7 (397.21)


   

(1s,19s)-5,6,14,15-tetramethoxy-1-methyl-17-oxa-9-azapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-2,4,6,12,14,16(20)-hexaene

(1s,19s)-5,6,14,15-tetramethoxy-1-methyl-17-oxa-9-azapentacyclo[10.6.2.0²,⁷.0⁹,¹⁹.0¹⁶,²⁰]icosa-2,4,6,12,14,16(20)-hexaene

C23H27NO5 (397.1889)


   

n-(2,6-dihydroxyphenyl)-3-[(1s,5s,6r,7s,9s,10s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propanimidic acid

n-(2,6-dihydroxyphenyl)-3-[(1s,5s,6r,7s,9s,10s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propanimidic acid

C23H27NO5 (397.1889)


   

(2r,3r,4as,4br,5'r,7r,8as)-2'-hydroxy-5'-[(1r)-1-hydroxyethyl]-4a,7-dimethyl-2-(prop-1-en-1-yl)-4b,5,6,7,8,8a-hexahydro-2h,5'h-spiro[phenanthrene-3,3'-pyrrole]-4,4'-dione

(2r,3r,4as,4br,5'r,7r,8as)-2'-hydroxy-5'-[(1r)-1-hydroxyethyl]-4a,7-dimethyl-2-(prop-1-en-1-yl)-4b,5,6,7,8,8a-hexahydro-2h,5'h-spiro[phenanthrene-3,3'-pyrrole]-4,4'-dione

C24H31NO4 (397.2253)


   

8,16-dimethoxy-4,4,5-trimethyl-8-(3-methylbut-2-en-1-yl)-3,12-dioxa-10-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1(9),2(6),10,13,15-pentaen-7-one

8,16-dimethoxy-4,4,5-trimethyl-8-(3-methylbut-2-en-1-yl)-3,12-dioxa-10-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1(9),2(6),10,13,15-pentaen-7-one

C23H27NO5 (397.1889)


   

n-[(3s,6r)-6-{[(2s,3s,4r,5s)-1,4-diamino-2,5,6-trihydroxyhexan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]propanimidic acid

n-[(3s,6r)-6-{[(2s,3s,4r,5s)-1,4-diamino-2,5,6-trihydroxyhexan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]propanimidic acid

C15H31N3O9 (397.206)


   

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

(1r,7ar)-7-({[(2r)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

C20H31NO7 (397.21)


   

2,5-diamino-4-hydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}octanedioic acid

2,5-diamino-4-hydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino}octanedioic acid

C14H27N3O10 (397.1696)


   

(3s,5r,8r,9s,11s,14r,17r,18s)-5,7-dimethyl-12-methylidene-10,15,16-trioxo-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl acetate

(3s,5r,8r,9s,11s,14r,17r,18s)-5,7-dimethyl-12-methylidene-10,15,16-trioxo-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-3-yl acetate

C23H27NO5 (397.1889)


   

13-amino-16-(hydroxymethyl)-20-methyl-11,14-dioxo-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10(15),12-diene-21-carbonitrile

13-amino-16-(hydroxymethyl)-20-methyl-11,14-dioxo-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10(15),12-diene-21-carbonitrile

C20H23N5O4 (397.175)


   

7-({[2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

7-({[2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C20H31NO7 (397.21)


   

(1r,3r,7s,11s,12r,14s,15r,19s)-11-hydroxy-7-methyl-17-methylidene-5-azahexacyclo[9.6.2.0³,¹⁵.0⁴,¹².0⁷,¹².0¹⁵,¹⁹]nonadec-4-en-14-yl (2r)-2-methylbutanoate

(1r,3r,7s,11s,12r,14s,15r,19s)-11-hydroxy-7-methyl-17-methylidene-5-azahexacyclo[9.6.2.0³,¹⁵.0⁴,¹².0⁷,¹².0¹⁵,¹⁹]nonadec-4-en-14-yl (2r)-2-methylbutanoate

C25H35NO3 (397.2617)


   

7-({[2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

7-({[2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 3-methylbut-2-enoate

C20H31NO7 (397.21)